Preliminary evidence supports circulating microRNAs as prognostic biomarkers for type 2 diabetes.
Elena FlowersA M KanayaY FukuokaI E AllenB CooperB E AouizeratPublished in: Obesity science & practice (2017)
Further studies are needed to determine which microRNAs are prognostic biomarkers of risk for type 2 diabetes versus consequences of impaired glucose metabolism. Additional future directions of this research are to differentiate whether microRNAs are prognostic and/or diagnostic biomarkers for risk for type 2 diabetes and predictive biomarkers of responses to risk reduction interventions.